Fundraising FoxNYBC Ventures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)Andy Orth(Chief Executive Officer)in
Co-investorsAN Venture PartnersARCH Venture PartnersSofinnova VenturesCasdin CapitalFidelity InvestmentsInvus+2 more
Vitestro is a Netherlands-based medical robotics company that develops Aletta, an autonomous robotic phlebotomy device for diagnostic blood collection in hospitals and laboratories.
HealthtechMedical DevicesRoboticsNetherlands, NL
Toon Overbeeke(Co-founder & CEO)inBrian Joseph(Co-founder)in
Co-investorsSonder CapitalIntervestInvest-NLMayo Clinic Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.